A year ago, we were overwhelmed by demand for RESI San Francisco, and to our surprise we had to close registrations two weeks early as we'd reached capacity. We have increased space over last year - however, RESI @ JPM at the Marines' Memorial Club is fast approaching sellout at 75% of capacity, and is expecting to host over 2000 scheduled and ad hoc meetings in one high energy day. This is a record-setting pace for Life Science Nation and the RESI Conference. We expect to close registration well before January 10th, perhaps even before New Year's Day!

The growth of RESI into a must-go-to event during JPMorgan week, is owed to our near-equal ratio of investors to fundraising executives paired with our unique partnering platform rich with investor data - an amazing feat that is only possible due to the strength of LSN's investor network...

The various panels that run throughout the day at every RESI conference serves to educate entrepreneurs on how various investors (VCs, corporates, angels, family offices, etc.) are looking at innovation in their specific sector and tactical guidance for how to approach and interact with them, including the nuances of commercializing these technologies and current happenings in their respective market. Medtech, especially in recent years, has taken a backseat to biopharma with lower valuations and fewer exit partners, however many early-stage investors and entrepreneurs alike, still believe there is value to be unlocked.

During RESI@JPM, a group of seasoned medical device investors will explore the state of the early-stage medtech space, discuss personal successes and failures in funding novel medical technologies and share with the entrepreneurs in the audience do's and don'ts of fundraising in this challenging sector.

 

Medical Device investor panelists will include the following: